Functional Characterization of the Semisynthetic Bile Acid Derivative INT-767, a Dual Farnesoid X Receptor and TGR5 Agonist
Giovanni Rizzo(Intercept Pharmaceuticals (United States)), Luciano Adorini(Intercept Pharmaceuticals (United States)), Giorgia Rizzo(Intercept Pharmaceuticals (United States)), Loredana Donadio, Bahman M. Sadeghpour, Stefano Orlandi, Xiaoxin X. Wang(Beijing Obstetrics and Gynecology Hospital), Mark Pruzanski(University of Padua), Daniela Passeri, Francesca Franco(Teikoku Pharma (United States)), Gianmario Ciaccioli, Tao Jiang(Third Affiliated Hospital of Southern Medical University), Moshe Levi(Georgetown University)
Cited by 185
Related Papers
Triglycerides and Cardiovascular Disease
|Circulation|2011|1.9k
Lipid Rafts Reconstituted in Model Membranes
|Biophysical Journal|2001|1.4k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k